0
Product Information
The CorDx Tyfast Flu A/B & COVID-19 Multiplex Rapid Test is a lateral flow immunoassay designed for the qualitative detection and differentiation of SARS-CoV-2, influenza A, and influenza B antigens. Utilizing anterior nasal swab specimens, this test delivers results in approximately 10 minutes, facilitating prompt identification of respiratory infections. Authorized under the FDA's Emergency Use Authorization, it serves as a valuable tool in point-of-care settings for individuals exhibiting symptoms within the first five days of onset.
Key Features:
- Detection Targets: SARS-CoV-2, Influenza A, and Influenza B antigens
- Sample Type: Anterior nasal swab
- Time to Results: Approximately 10 minutes
- Test Method: Lateral flow immunochromatographic assay
- Regulatory Status: FDA Emergency Use Authorization (EUA)
- Intended Use: For individuals with respiratory symptoms within the first five days of onset
